Kallmann Syndrome, also known as hypogonadism with anosmia, is related to hypogonadotropic hypogonadism 1 with or without anosmia and hypogonadotropic hypogonadism 2 with or without anosmia. An important gene associated with Kallmann Syndrome is PROKR2 (Prokineticin Receptor 2), and among its related pathways/superpathways are Signal Transduction and NF-KappaB Family Pathway. The drugs Zinc cation and Urofollitropin have been mentioned in the context of this disorder. Affiliated tissues include pituitary and breast, and related phenotypes are delayed puberty and hypogonadotropic hypogonadism